Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

van de Vijver, D A M C

Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. [electronic resource] - British journal of clinical pharmacology Aug 2002 - 168-70 p. digital

Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0306-5251

10.1046/j.1365-2125.2001.01491.x doi


Aged
Antidepressive Agents, Tricyclic--therapeutic use
Antiparkinson Agents--therapeutic use
Female
Follow-Up Studies
Humans
Levodopa--therapeutic use
Male
Middle Aged
Parkinson Disease--drug therapy
Selective Serotonin Reuptake Inhibitors--therapeutic use
Treatment Outcome